Send the following on WhatsApp
Continue to ChatRisk of severe hypocalcaemia with denosumab (Prolia): USFDA Drug safety communication https://publicsafetyandvigilance.com/2022/12/risk-of-severe-hypocalcaemia-with-denosumab-prolia-usfda-drug-safety-communication/